Pricing Log in Create free account

CAMP4 Therapeutics Corporation (CAMP) vs Fate Therapeutics, Inc. (FATE)

CAMP4 Therapeutics Corporation and Fate Therapeutics, Inc. are both Biotechnology companies. CAMP4 Therapeutics Corporation is the larger, with a market value of $254.8M against $223.1M — 1.1× the size. CAMP4 Therapeutics Corporation grew revenue faster over the last twelve months: 52.0% against −23.4%. Fate Therapeutics, Inc. has the higher net margin (−1,941.1% vs −2,276.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, CAMP4 Therapeutics Corporation leads on 7 and Fate Therapeutics, Inc. on 7.

Valuation

Metric CAMP FATE Biotechnology median
P/E n/m n/m 10.60
P/S 60.25 34.13 9.40
P/B 2.99 1.44 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 36.71 14.04 9.02
Earnings yield (49.68%) (57.07%) (32.88%)
Free cash flow yield (8.23%) (47.59%) (23.13%)

Profitability

Metric CAMP FATE Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (1,001.05%) (2,058.08%) 0.00%
Net margin (2,276.33%) (1,941.09%) 0.00%
Free cash flow margin (495.71%) (1,624.06%) 0.00%
Return on equity (146.12%) (60.75%) (51.96%)
Return on assets (109.89%) (39.89%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CAMP FATE Biotechnology median
Revenue growth (TTM) 52.00% (23.36%) 6.76%
EPS growth (last fiscal year) 76.00% 29.88% 29.88%
Revenue growth, 5-year CAGR — (26.71%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CAMP FATE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.42 4.85 4.97
Net debt to EBITDA 2.18 1.47 1.01

Dividend

Metric CAMP FATE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CAMP FATE Biotechnology median
Market cap 254.78m 223.08m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack